ALS Treatment NPT520-34 Being Tested in Phase 1 Trial, Neuropore Says – ALS News Today

ALS Treatment NPT520-34 Being Tested in Phase 1 Trial, Neuropore Says – ALS News Today
ALS Treatment NPT520-34 Being Tested in Phase 1 Trial, Neuropore Says  ALS News TodayNPT520-34, an investigational small molecule for the treatment of Parkinson's disease and amyotrophic lateral sclerosis (ALS), is being tested on healthy ... read more
Source: Google NewsPublished on 2019-05-13